Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Kaye

Showing results (31-40 of 418) with videos related to

Pageof 42
Sort By:
JACC. Heart Failure|June 1, 2019
Reply: The Importance of Baseline Physical Activity Level in Heart Failure With Preserved Ejection FractionAnna L Beale, Shane Nanayakkara, David M Kaye
Heart, Lung & Circulation|May 3, 2016
Role of Renal Oxidative Stress in the Pathogenesis of the Cardiorenal SyndromeBeverly Giam, David M Kaye, Niwanthi W Rajapakse
Heart Failure Clinics|March 6, 2019
Resting and Exercise Doppler Hemodynamics: How and Why?Shane Nanayakkara, David M Kaye, Thomas H Marwick
Annual Review of Medicine|January 12, 2008
Reversing advanced heart failure by targeting Ca2+ cyclingDavid M Kaye, Masahiko Hoshijima, Kenneth R Chien
International Journal of Cardiology|May 29, 2013
Integration of exercise evaluation into the algorithm for evaluation of patients with suspected heart failure with preserved ejection fractionVanessa P M van Empel, David M Kaye
Heart (British Cardiac Society)|November 3, 2017
The ageing heart: the systemic and coronary circulationShane Nanayakkara, Thomas H Marwick, David M Kaye
Clinical Science (London, England : 1979)|February 6, 2004
Continuous positive airway pressure decreases myocardial oxygen consumption in heart failureDavid M Kaye, Darren Mansfield, Matthew T Naughton
Journal of the American Heart Association|June 25, 2019
Impact of Sex on Ventricular-Vascular Stiffness and Long-Term Outcomes in Heart Failure With Preserved Ejection Fraction: TOPCAT Trial SubstudyAnna L Beale, Shane Nanayakkara, David M Kaye
Interventional Cardiology Clinics|June 6, 2017
Device-Based Therapy in the Prevention of Contrast-Induced NephropathyDion Stub, Stephen J Duffy, David M Kaye
Pharmacology & Therapeutics|May 20, 2015
Pathogenesis and treatment of the cardiorenal syndrome: Implications of L-arginine-nitric oxide pathway impairmentNiwanthi W Rajapakse, Shane Nanayakkara, David M Kaye
Pageof 42

Showing results (31-40 of 418) with videos related to

Sort By:
Pageof 42
JACC. Heart Failure|June 1, 2019
Reply: The Importance of Baseline Physical Activity Level in Heart Failure With Preserved Ejection FractionAnna L Beale, Shane Nanayakkara, David M Kaye
Heart, Lung & Circulation|May 3, 2016
Role of Renal Oxidative Stress in the Pathogenesis of the Cardiorenal SyndromeBeverly Giam, David M Kaye, Niwanthi W Rajapakse
Heart Failure Clinics|March 6, 2019
Resting and Exercise Doppler Hemodynamics: How and Why?Shane Nanayakkara, David M Kaye, Thomas H Marwick
Annual Review of Medicine|January 12, 2008
Reversing advanced heart failure by targeting Ca2+ cyclingDavid M Kaye, Masahiko Hoshijima, Kenneth R Chien
International Journal of Cardiology|May 29, 2013
Integration of exercise evaluation into the algorithm for evaluation of patients with suspected heart failure with preserved ejection fractionVanessa P M van Empel, David M Kaye
Heart (British Cardiac Society)|November 3, 2017
The ageing heart: the systemic and coronary circulationShane Nanayakkara, Thomas H Marwick, David M Kaye
Clinical Science (London, England : 1979)|February 6, 2004
Continuous positive airway pressure decreases myocardial oxygen consumption in heart failureDavid M Kaye, Darren Mansfield, Matthew T Naughton
Journal of the American Heart Association|June 25, 2019
Impact of Sex on Ventricular-Vascular Stiffness and Long-Term Outcomes in Heart Failure With Preserved Ejection Fraction: TOPCAT Trial SubstudyAnna L Beale, Shane Nanayakkara, David M Kaye
Interventional Cardiology Clinics|June 6, 2017
Device-Based Therapy in the Prevention of Contrast-Induced NephropathyDion Stub, Stephen J Duffy, David M Kaye
Pharmacology & Therapeutics|May 20, 2015
Pathogenesis and treatment of the cardiorenal syndrome: Implications of L-arginine-nitric oxide pathway impairmentNiwanthi W Rajapakse, Shane Nanayakkara, David M Kaye
Pageof 42